Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infection. Issue 1 (14th January 2015)
- Record Type:
- Journal Article
- Title:
- Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infection. Issue 1 (14th January 2015)
- Main Title:
- Amphotericin B deoxycholate nasal spray administered to hematopoietic stem cell recipients with prior fungal colonization of the upper airway passages is associated with low rates of invasive fungal infection
- Authors:
- Trifilio, S.M.
Heraty, R.
Zomas, A.
Zhou, Z.
Fong, J.L.
Liu, D.
Zhao, C.
Zhang, J.
Mehta, J. - Abstract:
- <abstract abstract-type="main" id="tid12324-abs-0001"> <title>Abstract</title> <sec id="tid12324-sec-0001" sec-type="section"> <title>Background</title> <p>Invasive fungal infections cause major problems during hematopoietic stem cell transplantation (HSCT). Fungal colonization of the upper airway passages occurs frequently, and may serve as a portal of entry for potentially life‐threatening fungal infections, especially in immunocompromised patients.</p> </sec> <sec id="tid12324-sec-0002" sec-type="section"> <title>Methods</title> <p>A clinical practice was instituted at Northwestern Memorial Hospital in Chicago in 2005, to administer amphotericin B deoxycholate nasal spray (ABNS) 0.5% to all HSCT recipients with fungal colonization of their nasal passages, in addition to standard oral antifungal prophylaxis.</p> </sec> <sec id="tid12324-sec-0003" sec-type="section"> <title>Results</title> <p>Among 1945 HSCT patients treated during the study period, 109 patients were identified with positive fungal surveillance cultures.</p> </sec> <sec id="tid12324-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Breakthrough fungal infections occurred in only 2 patients (2%), thus in this select group of HSCT recipients, ABNS administration is associated with a very low rate of breakthrough infection.</p> </sec> </abstract>
- Is Part Of:
- Transplant infectious disease. Volume 17:Issue 1(2015)
- Journal:
- Transplant infectious disease
- Issue:
- Volume 17:Issue 1(2015)
- Issue Display:
- Volume 17, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 17
- Issue:
- 1
- Issue Sort Value:
- 2015-0017-0001-0000
- Page Start:
- 1
- Page End:
- 6
- Publication Date:
- 2015-01-14
- Subjects:
- Transplantation of organs, tissues, etc -- Complications -- Periodicals
Communicable diseases -- Periodicals
Infection -- Periodicals
617.01 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=mid ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/tid.12324 ↗
- Languages:
- English
- ISSNs:
- 1398-2273
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9024.988700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3073.xml